Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
D019797:3-Iodobenzylguanidine; D014408:Biomarkers, Tumor / Q000652:urine; D005260:Female; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D007223:Infant; D007564:Japan / Q000453:epidemiology; D008297:Male; D008403:Mass Screening / Q000379:methods* / Q000706:statistics & numerical data; D009447:Neuroblastoma / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000652:urine; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods* / Q000706:statistics & numerical data; D014642:Vanilmandelic Acid / Q000652:urine; D014915:Whole-Body Counting / Q000379:methods
D014408:Biomarkers, Tumor; D019275:Radiopharmaceuticals; D019797:3-Iodobenzylguanidine; D014642:Vanilmandelic Acid; D006719:Homovanillic Acid